🚀Product Launch Announcement: Enzamale 40 (Enzalutamide 40mg) Capsules
We are proud to introduce Enzamale 40 (Enzalutamide 40 mg) capsule is an advanced androgen-receptor inhibitor formulated to support the treatment of metastatic and non-metastatic castration-resistant prostate cancer (mCRPC & nmCRPC).
Designed with high-purity API and optimized bioavailability, Enzamale delivers consistent therapeutic performance by blocking key androgen-receptor signaling pathways responsible for tumor progression. Its patient-friendly oral capsule format ensures comfort, compliance, and reliable everyday dosing.
🔍 Product Overview
Generic Name: Enzalutamide
Strength: 40mg
Formulation: Oral Capsule
Primary Indications:
Enzamale 40 (Enzalutamide 40mg) capsule is indicated for the treatment of prostate cancer. This includes patients who have:
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
- Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
- Progression despite androgen deprivation therapy (ADT)
- Disease advancement following prior therapies such as docetaxel or abiraterone, as clinically appropriate
Mechanism of Action:
Enzamale 40 (Enzalutamide 40mg) capsule is a potent androgen receptor (AR) inhibitor that works through a triple-action blockade:
- Prevents androgen binding to the androgen receptor
- Inhibits nuclear translocation of the activated androgen receptor
- Blocks AR-driven DNA transcription that promotes tumor cell growth
By disrupting these key pathways, Enzalutamide reduces prostate cancer cell proliferation, slows disease progression, and enhances clinical control in hormone-driven prostate cancer cases.
💡 Key Benefits
- Robust AR Inhibition: Effectively blocks androgen-driven tumor growth and disease progression.
- Clinically Proven Outcomes: Demonstrated improvement in progression-free and overall survival in prostate cancer patients.
- Convenient Daily Dosing: Easy-to-swallow capsules designed for long-term treatment adherence.
- High Quality & Purity: Manufactured to stringent GMP standards for consistent efficacy and safety.
- Improved Patient Quality of Life: Helps manage symptoms while supporting long-term clinical stability.
🎯 Target Audience
- Oncologists & Urologists treating CRPC patients
- Cancer Treatment Centers & Hospitals requiring trusted hormonal therapy options
- Pharmacies & Oncology Distributors seeking premium-quality cancer care medications
- Patients diagnosed with mCRPC or nmCRPC, under medical supervision
🏥 Commitment to Clinical Excellence
Enzamale 40 is developed through a rigorous quality-controlled manufacturing process, ensuring each capsule meets global standards for potency, purity, and consistency.
Our commitment is to advance cancer care through reliable formulations, scientific integrity, and continuous product innovation.
We partner closely with healthcare professionals to deliver dependable therapeutic solutions that support better treatment outcomes.
📦 Availability
Enzamale 40 (Enzalutamide 40 mg) Capsules are now available through:
For detailed prescribing information, clinical study data, or patient support materials, please get in touch with our medical team or visit Enzamale 40.
Enzamale 40 – Fighting Cancer with Precision.
